Blar i Institutt for klinisk og molekylær medisin på forfatter "Aasarød, Knut"
-
Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis
Øvrehus, Marius Altern; Oldereid, Tine Simensen; Dadfar, Aydin; Bjørneklett, Rune; Aasarød, Knut; Fogo, Agnes B.; Ix, Joachim H.; Hallan, Stein (Peer reviewed; Journal article, 2020)Introduction Hypertensive nephrosclerosis is considered the second most common cause of end-stage renal disease (ESRD), but it is still an insufficiently studied and controversial disease entity. More information on the ... -
Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
Sriskandarajah, Sanjeevan; Aasarød, Knut; Skrede, Steinar; Knoop, Thomas; Reisæter, Anna Varberg; Bjørneklett, Rune (Peer reviewed; Journal article, 2014)Background: Glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased mortality and a high risk of end-stage renal disease (ESRD). Here, we investigated whether the ... -
Reference limits for chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and carcinoembryonic antigen in patients with chronic kidney disease
Mikkelsen, Gustav; Åsberg, Arne; Hultström, Maria Elisabeth; Aasarød, Knut; Hov, Gunhild Garmo (Journal article; Peer reviewed, 2017)Background Patients with chronic kidney disease (CKD) may have increased plasma concentrations of some tumor markers even when no cancer is present. Previous studies have indicated that plasma concentrations of chromogranin ...